Author Question: How did Latan and Darley (1968) vary the number of bystanders in their experimental study of the ... (Read 139 times)

RRMR

  • Hero Member
  • *****
  • Posts: 557
How did Latan and Darley (1968) vary the number of bystanders in their experimental study of the effects of the number of witnesses exposed to an emergency?
 
  a. They allowed participants to choose whether to participate in a group or in a one-on-one discussion.
  b. They asked participants whether they would like to be engaged in a discussion with one, three, or six other individuals.
  c. Participants who arrived first were assigned to a large group condition, and those who arrived later were assigned to a small group condition.
  d. They randomly assigned participants to one of three conditions: several witnesses, few witnesses, or one witness.

Question 2

Participants in the Latan and Darley (1968) experimental study of the effects of group size on intervention in an emergency utilized
 
  a. audiotapes of the Kitty Genovese murder.
  b. a staged assault on the experimenter.
  c. an audiotaped seizure.
  d. participants' reports of what they would do in an emergency.



IRincones

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

Answer: D

Answer to Question 2

Answer: C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

In most cases, kidneys can recover from almost complete loss of function, such as in acute kidney (renal) failure.

Did you know?

You should not take more than 1,000 mg of vitamin E per day. Doses above this amount increase the risk of bleeding problems that can lead to a stroke.

Did you know?

Most fungi that pathogenically affect humans live in soil. If a person is not healthy, has an open wound, or is immunocompromised, a fungal infection can be very aggressive.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

For a complete list of videos, visit our video library